This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Darktrace Valuation

Is DRKT.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DRKT.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DRKT.F ($7.57) is trading below our estimate of fair value ($8.93)

Significantly Below Fair Value: DRKT.F is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DRKT.F?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for DRKT.F. This is calculated by dividing DRKT.F's market cap by their current preferred multiple.
What is DRKT.F's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	US$4.97b

DRKT.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7.5x
Enterprise Value/EBITDA	43.2x
PEG Ratio	5.8x

Price to Earnings Ratio vs Peers

How does DRKT.F's PE Ratio compare to its peers?

The above table shows the PE ratio for DRKT.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	33x
QLYS Qualys	26.9x	2.2%	US$4.4b
CVLT Commvault Systems	38.8x	-23.3%	US$6.8b
PRGS Progress Software	33.2x	24.5%	US$2.8b
DLB Dolby Laboratories	32.9x	13.7%	US$7.0b
DRKT.F Darktrace	44.8x	7.8%	US$3.7b

Price-To-Earnings vs Peers: DRKT.F is expensive based on its Price-To-Earnings Ratio (44.8x) compared to the peer average (33.9x).

Price to Earnings Ratio vs Industry

How does DRKT.F's PE Ratio compare vs other companies in the US Software Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	16.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	16.8%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: DRKT.F is expensive based on its Price-To-Earnings Ratio (44.8x) compared to the US Software industry average (38.7x).

Price to Earnings Ratio vs Fair Ratio

What is DRKT.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DRKT.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	44.8x
Fair PE Ratio	30.7x

Price-To-Earnings vs Fair Ratio: DRKT.F is expensive based on its Price-To-Earnings Ratio (44.8x) compared to the estimated Fair Price-To-Earnings Ratio (30.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DRKT.F forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	n/a	US$8.04 0%	2.5%	US$8.27	US$7.55	n/a	11
Oct ’25	US$7.62	US$8.04 +5.6%	2.5%	US$8.27	US$7.55	n/a	11
Sep ’25	US$7.36	US$8.08 +9.8%	2.4%	US$8.31	US$7.58	n/a	12
Aug ’25	US$7.32	US$7.78 +6.3%	2.1%	US$7.96	US$7.27	n/a	12
Jul ’25	US$7.37	US$7.78 +5.7%	2.1%	US$7.96	US$7.27	n/a	12
Jun ’25	US$7.47	US$7.86 +5.2%	2.6%	US$8.28	US$7.32	n/a	13
May ’25	US$7.50	US$7.90 +5.3%	8.4%	US$9.99	US$7.18	n/a	12
Apr ’25	US$5.68	US$6.68 +17.7%	19.1%	US$8.85	US$3.41	n/a	16
Mar ’25	US$4.52	US$6.54 +44.6%	19.4%	US$8.92	US$3.44	n/a	15
Feb ’25	US$4.40	US$6.54 +48.6%	19.4%	US$8.92	US$3.44	n/a	15
Jan ’25	US$4.60	US$6.67 +44.9%	19.7%	US$8.88	US$3.30	n/a	14
Dec ’24	US$4.36	US$6.65 +52.5%	19.5%	US$8.89	US$3.30	n/a	14
Nov ’24	US$4.23	US$6.18 +46.2%	18.2%	US$7.89	US$2.91	n/a	14
Oct ’24	US$5.09	US$6.13 +20.5%	18.1%	US$7.93	US$2.93	US$7.62	14
Sep ’24	US$4.58	US$6.15 +34.4%	22.5%	US$8.27	US$3.05	US$7.36	15
Aug ’24	US$4.85	US$6.05 +24.8%	22.5%	US$8.36	US$3.09	US$7.32	15
Jul ’24	US$3.85	US$5.24 +36.1%	28.2%	US$8.03	US$2.96	US$7.37	15
Jun ’24	US$3.49	US$5.24 +50.1%	28.2%	US$8.03	US$2.96	US$7.47	15
May ’24	US$3.34	US$5.68 +70.0%	23.4%	US$8.09	US$3.11	US$7.50	12
Apr ’24	US$3.12	US$5.47 +75.3%	24.4%	US$8.05	US$3.10	US$5.68	13
Mar ’24	US$3.17	US$5.38 +70.0%	25.2%	US$7.83	US$3.01	US$4.52	12
Feb ’24	US$2.75	US$5.56 +102.3%	25.5%	US$8.04	US$3.09	US$4.40	12
Jan ’24	US$3.15	US$6.27 +98.9%	17.2%	US$7.96	US$3.92	US$4.60	12
Dec ’23	US$4.07	US$6.27 +53.9%	17.2%	US$7.96	US$3.92	US$4.36	12
Nov ’23	US$4.17	US$5.82 +39.5%	19.3%	US$7.35	US$3.62	US$4.23	10

Analyst Forecast: Target price is less than 20% higher than the current share price.